Strategic collaborations
Our collaboration strategy is a key element in executing our corporate strategy. We are committed to developing transformational therapies that address high unmet needs in oncology and immune-oncology. We strive to be a partner of choice and enter collaborations and strategic partnerships with leading biopharma companies to further broaden our oncology pipeline, to advance our clinical-stage programs following clinical proof-of-concept, so we eventually commercialize differentiated therapies that matter to oncology patients.